Litigation Details for FERRING B.V. v. ACTAVIS, INC. (D.N.J. 2015)
✉ Email this page to a colleague
FERRING B.V. v. ACTAVIS, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-06-23 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-01-04 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | Referred To | Cathy L. Waldor | |
| Parties | ACTAVIS, INC. | ||
| Patents | 9,060,939 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in FERRING B.V. v. ACTAVIS, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for FERRING B.V. v. ACTAVIS, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-05-26 | 23 | the holder of United States Patent Number 9,060,939 (“the ’939 patent”), issued June 23, 2015, which…in a patent or the use of which is claimed in a patent before the expiration of such patent. …are met once a patent owner alleges that another’s filing of an ANDA infringes its patent under § 271(… drug claimed in a patent or the use of which is claimed in a patent . . . if the purpose … ’939 patent at the time that Defendant Watson Labs. filed their ANDA; in fact, this patent did not | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
